Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Eradication of H. pylori infection reduces risk for metachronous gastric cancer

Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection, reports the latest issue of the Alimentary Pharmacology & Therapeutics.

News image

Patients who have undergone endoscopic resection of early gastric cancers are at risk for metachronous gastric neoplasm.

Dr Jeon and colleagues from Korea determined whether serum level of pepsinogen, a marker of gastric atrophy, can determine which patients who have undergone endoscopic submucosal dissection for early gastric cancers are at risk for metachronous gastric neoplasm.

The team also investigated the effects of Helicobacter pylori eradication on metachronous gastric neoplasm incidence.

The research team performed a retrospective study of 590 consecutive patients who underwent endoscopic submucosal dissection for early gastric cancers, from 2008 to 2013 at a tertiary centre in South Korea.

Serum levels of pepsinogen were measured at the time of endoscopic submucosal dissection and Helicobacter pylori infection status were recorded.

In case of proven presence of current Helicobacter pylori infection, eradication treatment was provided.

64 patients developed metachronous gastric neoplasms
Alimentary Pharmacology & Therapeutics

Patients underwent follow-up endoscopies at 3 months, 9 months, and each year after the procedure to detect neoplasms and were tested for Helicobacter pylori infection.

The team measured serum levels of pepsinogen at these time points from 442 of the patients.

The main and sub-cohorts were assessed for baseline characteristics, Helicobacter pylori infection, serum level of pepsinogen, and metachronous gastric neoplasm lesions.

During a median follow-up period of 48 months, 64 patients developed metachronous gastric neoplasms.

The research team observed that in the main cohort, risk factors for metachronous gastric neoplasm included persistent Helicobacter pylori infection, and serum ratio of pepsinogen I:pepsinogen II of 3 or less at the time of endoscopic submucosal dissection.

The team found that among patients with serum pepsinogen measurements, persistent Helicobacter pylori infection, and persistent decrease in mean serum ratio of pepsinogen I:pepsinogen II to 3 or less were associated with increased risk of metachronous gastric neoplasm.

Dr Jeon's team comments, "In a retrospective analysis of patients who underwent endoscopic resection of early gastric cancers, eradication of Helicobacter pylori infection reduced risk for metachronous gastric neoplasm."

"Serum ratio of pepsinogen I:pepsinogen II of 3 or less also increase risk of metachronous gastric neoplasm after endoscopic submucosal dissection."

Aliment Pharmacol Ther 2017: 46(8): 758–767
26 September 2017

Go to top of page Email this page Email this page to a colleague

 23 May 2018 
High body mass index is and ulcerative colitis
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Fecal incontinence and quality of life in IBD
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Post‐operative complications in elderly IBD
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Esophageal dilatation in clinical practice 
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's
 24 April 2018 
Microbiome in athletes vs sedentary subjects
 23 April 2018 
Genome-wide study on HBV-related acute-on-chronic liver failure
 23 April 2018 
Antibody suitable for further clinical development to complement existing therapeutic strategies for HCV
 23 April 2018 
Sleep deprivation and NAFLD in the USA
 20 April 2018 
Two annexin A11 epitopes targeted by IgG1 and IgG4 autoantibodies were shared between patients with IAC/AIP and IgG4 antibodies blocked binding of IgG1 antibodies to the shared annexin A11 epitopes

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us